AZD9838
/ AstraZeneca
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 08, 2024
ARTEMIS-C: A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19
(clinicaltrials.gov)
- P1 | N=243 | Active, not recruiting | Sponsor: AstraZeneca | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
March 15, 2024
ARTEMIS-C: A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19
(clinicaltrials.gov)
- P1 | N=240 | Recruiting | Sponsor: AstraZeneca | N=90 ➔ 240
Enrollment change • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
December 11, 2023
ARTEMIS-C: A Randomized Trial Evaluating a mRNA VLP Vaccine's Immunogenicity and Safety for COVID-19
(clinicaltrials.gov)
- P1 | N=90 | Recruiting | Sponsor: AstraZeneca | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 3
Of
3
Go to page
1